Updates are available Correction dated 2024-09-26
Click to view Correction: https://doi.org/10.1186/s13063-024-08504-z
-
Authors
Arvieux, Catherine
Tidadini, Fatah
Barbois, Sandrine
Fontas, Eric
Carles, Michel
Gridel, Victor
Orban, Jean-Christophe
Quesada, Jean-Louis
Foote, Alison
Cruzel, Coralie
Anthony, Sabine
Bulsei, Julie
Hivelin, Céline
Massalou, Damien
-
Funding
Funding for this research was provided by:
French Ministry of Health, Hospital clinical research program (PHRC) 2021 to Nice University Hospital (PHRC-21-0175)
- License Information
-
More Information
Article History
Received: 24 April 2024
Accepted: 11 July 2024
First Online: 9 September 2024
Declarations
:
: The trial protocol was approved by the French ethics committee (“Comité pour la protection de personnes” CPP) Ouest II on November 22, 2022, and the most recent amended version on August 2, 2023 (IRB n° 2022-A01848-35). Signature of the written informed consent form by the patient is required prior to inclusion in the trial. If the patient is a minor, a signature of the written informed consent form by both parents or their legal representative(s) is required.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.
: The authors declare that they have no competing interests.
